Related Experiment Video
Updated: Jun 5, 2026

Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
Power and robustness of three whole genome association mapping approaches in selected populations
M Erbe1, F Ytournel, E C G Pimentel
1Department of Animal Sciences, Animal Breeding and Genetics Group, Georg-August-University Goettingen, Goettingen, Germany. merbe@gwdg.de
Abstract:
Selection is known to influence the linkage disequilibrium (LD) pattern in livestock populations. Spurious LD may lead to a higher number of false-positive signals in whole genome association mapping experiments. We compared three approaches for whole genome association mapping in a simulation study: single marker regression (SMR), a two-step approach, which analyses residuals corrected for family effects with an SMR (GRAMMAR), and a combined linkage and LD approach, which applies the quantitative transmission disequilibrium test to the Mendelian sampling term (MTDT). Three different scenarios were simulated: idealized random mating, limited number of parents and directional selection. The number of false-positive associations increased when the number of parents was limited. Mapping accuracy was the worst in the scenario with directional selection for all approaches. As SMR produced a high number of false-positive signals in small populations, results of whole genome scans in livestock analysed with SMR should be considered with caution. GRAMMAR was the most accurate approach, but also the least powerful one. The Bonferroni-corrected significance threshold seemed to be too stringent for this approach. Results obtained with MTDT changed only slightly with selected populations. MTDT combined sufficient power with a manageable number of false-positive associations in all scenarios.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Modern Molecular Taxonomy
Evolutionary Relationships through Genome Comparisons
Pharmacogenomics: Identification of New Drug Targets
